ArticleSingapore medical journal2019
Vulvar basal cell carcinoma: clinical features and treatment outcomes from a tertiary care centre.
Article in Singapore medical journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 18 citations in OpenAlex.
- Rare occurrence of penoscrotal basal cell carcinoma: Clinicopathologic findings from a single institution cohort and comprehensive literature review.Virchows Archiv : an international journal of pathology · 2025Article
- Pigmented vulvar basal cell carcinoma in a Hispanic patient treated with Mohs micrographic surgery.International journal of women's dermatology · 2023Article
- Vulvar Basal Cell Carcinoma in Postmenopausal Women: Two Case Reports.Journal of menopausal medicine · 2023Article
- Treatment of vulvar basal cell carcinoma with Slow-Mohs micrographic surgery A case report.Clinical case reports · 2022Article
- Giant basal cell carcinoma of the vulva successfully treated with Sonidegib.Dermatologic therapy · 2022Article
- Authors' reply.Singapore medical journal · 2020Article
- Comment on: Vulvar basal cell carcinoma: clinical features and treatment outcomes from a tertiary care centre.Singapore medical journal · 2020Article
- Basal Cell Carcinoma of the External Genitalia: A Population-Based Analysis.Frontiers in oncology · 2020Article
- Vulvar malignancies: an interdisciplinary perspective.Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG · 2019Review
- Basosquamous Carcinoma Arising from the Vulva: A Case Report.Case reports in oncologyArticle
Corrections and comments
- Commented on by
Authors and funding
8 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We retrospectively reviewed the clinical features, management and outcomes of patients diagnosed with basal cell carcinoma (BCC) of the vulva at the Gynaecological Cancer Centre, KK Women's and Children's Hospital, Singapore, between 1 January 2000 and 28 February 2014. Patients with vulvar BCC were identified from the cancer registry, and their medical records reviewed and analysed. A total of 11 patients with vulvar BCC were identified. Mean age at diagnosis was 63 (range 30-85) years. Ethnically, ten patients were Chinese and one was Malay. Average time from onset of symptoms to diagnosis was 13.8 (range 2-60) months. The most common presenting symptoms were lump and pruritus. All patients were managed surgically. Recurrence was noted in only one patient. Vulvar BCC, although rare, has an excellent prognosis when managed appropriately. Histological diagnosis of all persistent papules, plaques and pigmented lesions is important for early diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.